Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Jun;82(11):1783–1788. doi: 10.1054/bjoc.2000.1142

Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy

V Jenkins 1, L Fallowfield 1
PMCID: PMC2363224  PMID: 10839291

Abstract

This paper reports on the reasons why patients agreed to or declined entry into randomized trials of cancer following discussions conducted by clinicians in both District General and University Hospitals. Two hundred and four patients completed a 16-item questionnaire following the consultation, of these 112 (55%) were women with breast cancer. Overall results showed that 147 (72.1%) patients accepted entry to a randomized clinical trial (RCT). The main reasons nominated for participating in a trial were that ‘others will benefit’ (23.1%) and ‘trust in the doctor’ (21.1%). One of the main reasons for declining trial entry was that patients were ‘worried about randomization’ (19.6%). There was a significantly higher acceptance rate for trials providing active treatment in every arm 98 (80.6%) compared with those trials with a no treatment arm 46 (60.5%), χ2test P = 0.003. The study outlines a number of factors that appear to influence a patient’s decision to accept or decline entry into an RCT of cancer therapy. An important factor is whether or not the trial offers active treatment in all arms of the study. Communication that promotes trust and confidence in the doctor is also a powerful motivating influence. © 2000 Cancer Research Campaign

Keywords: cancer, randomized clinical trials, communication, trial participation

Full Text

The Full Text of this article is available as a PDF (61.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baum M. New approach for recruitment into randomised controlled trials. Lancet. 1993 Mar 27;341(8848):812–813. doi: 10.1016/0140-6736(93)90573-y. [DOI] [PubMed] [Google Scholar]
  2. Corbett F., Oldham J., Lilford R. Offering patients entry in clinical trials: preliminary study of the views of prospective participants. J Med Ethics. 1996 Aug;22(4):227–231. doi: 10.1136/jme.22.4.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ellis P. M., Butow P. N. Focus group interviews examining attitudes to randomised trials among breast cancer patients and the general community. Aust N Z J Public Health. 1998 Aug;22(5):528–531. doi: 10.1111/j.1467-842x.1998.tb01432.x. [DOI] [PubMed] [Google Scholar]
  4. Fallowfield L. J., Jenkins V., Brennan C., Sawtell M., Moynihan C., Souhami R. L. Attitudes of patients to randomised clinical trials of cancer therapy. Eur J Cancer. 1998 Sep;34(10):1554–1559. doi: 10.1016/s0959-8049(98)00193-2. [DOI] [PubMed] [Google Scholar]
  5. Fallowfield L., Ratcliffe D., Souhami R. Clinicians' attitudes to clinical trials of cancer therapy. Eur J Cancer. 1997 Nov;33(13):2221–2229. doi: 10.1016/s0959-8049(97)00253-0. [DOI] [PubMed] [Google Scholar]
  6. Featherstone K., Donovan J. L. Random allocation or allocation at random? Patients' perspectives of participation in a randomised controlled trial. BMJ. 1998 Oct 31;317(7167):1177–1180. doi: 10.1136/bmj.317.7167.1177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gotay C. C. Accrual to cancer clinical trials: directions from the research literature. Soc Sci Med. 1991;33(5):569–577. doi: 10.1016/0277-9536(91)90214-w. [DOI] [PubMed] [Google Scholar]
  8. Jenkins V. A., Fallowfield L. J., Souhami A., Sawtell M. How do doctors explain randomised clinical trials to their patients? Eur J Cancer. 1999 Aug;35(8):1187–1193. doi: 10.1016/s0959-8049(99)00116-1. [DOI] [PubMed] [Google Scholar]
  9. Kardinal C. G. Ethical issues in cancer clinical trials. J La State Med Soc. 1994 Aug;146(8):359–361. [PubMed] [Google Scholar]
  10. Leonard R. C. The advancement of high-dose chemotherapy and dose intensification schedules. Ann Oncol. 1997;8 (Suppl 3):S3–S6. [PubMed] [Google Scholar]
  11. Llewellyn-Thomas H. A., McGreal M. J., Thiel E. C., Fine S., Erlichman C. Patients' willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation. Soc Sci Med. 1991;32(1):35–42. doi: 10.1016/0277-9536(91)90124-u. [DOI] [PubMed] [Google Scholar]
  12. Mattson M. E., Curb J. D., McArdle R. Participation in a clinical trial: the patients' point of view. Control Clin Trials. 1985 Jun;6(2):156–167. doi: 10.1016/0197-2456(85)90121-7. [DOI] [PubMed] [Google Scholar]
  13. Penman D. T., Holland J. C., Bahna G. F., Morrow G., Schmale A. H., Derogatis L. R., Carnrike C. L., Jr, Cherry R. Informed consent for investigational chemotherapy: patients' and physicians' perceptions. J Clin Oncol. 1984 Jul;2(7):849–855. doi: 10.1200/JCO.1984.2.7.849. [DOI] [PubMed] [Google Scholar]
  14. Sheldon J. M., Fetting J. H., Siminoff L. A. Offering the option of randomized clinical trials to cancer patients who overestimate their prognoses with standard therapies. Cancer Invest. 1993;11(1):57–62. doi: 10.3109/07357909309020261. [DOI] [PubMed] [Google Scholar]
  15. Slevin M., Mossman J., Bowling A., Leonard R., Steward W., Harper P., McIllmurray M., Thatcher N. Volunteers or victims: patients' views of randomised cancer clinical trials. Br J Cancer. 1995 Jun;71(6):1270–1274. doi: 10.1038/bjc.1995.245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Smyth J. F., Mossman J., Hall R., Hepburn S., Pinkerton R., Richards M., Thatcher N., Box J. Conducting clinical research in the new NHS: the model of cancer. United Kingdom Coordinating Committee on Cancer Research. BMJ. 1994 Aug 13;309(6952):457–461. doi: 10.1136/bmj.309.6952.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Taylor K. M., Kelner M. Interpreting physician participation in randomized clinical trials: the Physician Orientation Profile. J Health Soc Behav. 1987 Dec;28(4):389–400. [PubMed] [Google Scholar]
  18. Welton A. J., Vickers M. R., Cooper J. A., Meade T. W., Marteau T. M. Is recruitment more difficult with a placebo arm in randomised controlled trials? A quasirandomised, interview based study. BMJ. 1999 Apr 24;318(7191):1114–1117. doi: 10.1136/bmj.318.7191.1114. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES